|
Market Closed -
Nasdaq
04:00:00 03/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 302.96 USD | +0.07% |
|
+0.48% | +60.24% |
| 09-25 | Barclays Initiates Ligand Pharmaceuticals at Overweight With $345 Price Target | MT |
| 09-24 | Ligand Pharmaceuticals Invests Up to $47 Million in AvenCell | MT |
| Market Cap | 6.04B 5.37B 5.01B 4.57B 8.61B 581B 8.69B 60.61B 23.49B 297B 22.68B 22.18B 953B | P/E 2026 * |
58x | P/E 2027 * | 35.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.04B 5.37B 5.01B 4.57B 8.61B 581B 8.69B 60.61B 23.49B 297B 22.68B 22.18B 953B | EV / Sales 2026 * |
20.9x | EV / Sales 2027 * | 15.8x |
| Free-Float |
97.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LGND | Delayed | |
CBOE
| LGND | Real-time | |
|
Tradegate
| LGDN | Real-time | |
|
Deutsche Boerse AG
| LGDN | Delayed | |
|
Börse Stuttgart
| LGDN | Delayed | |
|
Boerse Muenchen
| LGDN | Real-time | |
|
Berne S.E.
| LGDN | End-of-day quote |
Last Transcript: Ligand Pharmaceuticals Incorporated
| 1 day | +0.07% | ||
| 1 week | +0.48% | ||
| Current month | -3.01% | ||
| 1 month | +4.56% | ||
| 3 months | -5.19% | ||
| 6 months | +51.79% | ||
| Current year | +60.24% |
| 1 week | 299.7 |  | 317.23 |
| 1 month | 270.77 | | 317.23 |
| Current year | 175.89 | | 326.63 |
| 1 year | 175.89 | | 326.63 |
| 3 years | 49.24 | | 326.63 |
| 5 years | 49.24 | | 326.63 |
| 10 years | 49.24 | | 326.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 65 | 05/12/2022 |
Melanie Herman
DFI | Director of Finance/CFO | 47 | 21/05/2015 |
Octavio Espinoza
DFI | Director of Finance/CFO | 56 | 01/11/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Kozarich
CHM | Chairman | 76 | 01/03/2003 |
Jason Aryeh
BRD | Director/Board Member | 57 | 27/09/2006 |
Todd Davis
BRD | Director/Board Member | 65 | 01/03/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/9/26 | Tax | Director | -115 | 0.0006% | ||
| 10/9/26 | Sell | Director | -1,200 | 0.0060% | ||
| 3/9/26 | Sell | General Counsel | -5,000 | 0.0251% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.07% | +0.48% | +67.39% | +415.68% | 6.04B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.68% | -3.00% | +30.20% | +94.58% | 370.32B | |
| Weighted average by Cap. | -0.60% | -3.32% | +29.14% | +71.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 290M 257M 240M 219M 413M 27.84B 417M 2.91B 1.13B 14.23B 1.09B 1.06B 45.68B | 381M 339M 316M 288M 544M 36.67B 549M 3.83B 1.48B 18.75B 1.43B 1.4B 60.17B |
| Net income | 112M 99.15M 92.54M 84.35M 159M 10.73B 161M 1.12B 434M 5.48B 419M 410M 17.6B | 187M 167M 155M 142M 267M 18.02B 270M 1.88B 729M 9.21B 704M 689M 29.57B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | US$302.96 | +0.07% | 179,228 |
| 01/10/26 | US$302.74 | -3.08% | 374,019 |
| 30/09/26 | US$312.37 | +0.65% | 505,862 |
| 29/09/26 | US$310.36 | -1.19% | 430,961 |
| 28/09/26 | US$314.10 | +4.17% | 241,742 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LGND Stock
Select your edition
All financial news and data tailored to specific country editions
